The fact that the UPS degrades tau protein [10, 11] and that a pharmacological proteasome inhibition favors the aggregation of tau [12] supports the idea that there is a causal relationship between NFTs formation and UPS dysfunction detected in AD patients. This evidence concerns the gene MAPT and Alzheimer disease.